India Opposes 10-Nation WTO Proposal To Curb Drug Counterfeits
This article was originally published in PharmAsia News
Executive Summary
India had adopted a position opposing a proposal by 10 World Trade Organization members, most of them major entities, to block the counterfeiting of patented innovative drugs.
India had adopted a position opposing a proposal by 10 World Trade Organization members, most of them major entities, to block the counterfeiting of patented innovative drugs. India’s government contends the agreement was adopted at the urging of multinational drug makers that fear generic competition, primarily from India. At issue is the Anti-Counterfeiting Trade Agreement signed by Australia, Canada, Japan, Mexico, Morocco, New Zealand, Singapore, South Korea, Switzerland and the U.S. India said the proposal was an attack on generics produced not only by it, but by makers in Bangladesh, Brazil, China and Thailand. (Click here for more)
“India Opposes Pharma Piracy Pact By 10 Nations” – Economic Times (India) (3/3/12)